US academic drug discovery.
作者信息
Frye Stephen, Crosby Marina, Edwards Teresa, Juliano Rudolph
出版信息
Nat Rev Drug Discov. 2011 Jun;10(6):409-10. doi: 10.1038/nrd3462.
Abstract
摘要
相似文献
1
US academic drug discovery.美国学术性药物研发
Nat Rev Drug Discov. 2011 Jun;10(6):409-10. doi: 10.1038/nrd3462.
2
NIPTE: a multi-university partnership supporting academic drug development.NIPTE：一个支持学术药物开发的多大学合作关系。
Drug Discov Today. 2013 Oct;18(19-20):916-21. doi: 10.1016/j.drudis.2013.05.014. Epub 2013 May 31.
3
Mitigating risk in academic preclinical drug discovery.减轻临床前学术药物研发中的风险。
Nat Rev Drug Discov. 2015 Apr;14(4):279-94. doi: 10.1038/nrd4578.
4
Grants4Targets: an open innovation initiative to foster drug discovery collaborations.“资助4靶点”：一项促进药物研发合作的开放式创新倡议。
Nat Rev Drug Discov. 2015 Jan;14(1):74-6. doi: 10.1038/nrd3078-c2. Epub 2014 Nov 28.
5
A view from the future: the challenge for academic medicine in northern California.来自未来的视角：北加利福尼亚学术医学面临的挑战。
Acad Med. 1995 Feb;70(2):87-9. doi: 10.1097/00001888-199502000-00007.
6
Open innovation networks between academia and industry: an imperative for breakthrough therapies.学术界与产业界之间的开放式创新网络：突破性疗法的必要条件。
Nat Med. 2009 May;15(5):502-7. doi: 10.1038/nm0509-502.
7
NerveCenter: events, people, and issues in academic neurology.神经中枢：学术神经学中的事件、人物及问题
Ann Neurol. 2008 May;63(5):A14-7. doi: 10.1002/ana.21257.
8
Universities and sponsored research: indirect cost recovery and the law of diminishing return.大学与赞助研究：间接成本回收与收益递减规律
Hepatology. 2015 Jun;61(6):1776-8. doi: 10.1002/hep.27776. Epub 2015 Apr 13.
9
The future is much closer collaboration between the pharmaceutical industry and academic medical centers.未来制药行业与学术医疗中心之间将有更紧密的合作。
Clin Pharmacol Ther. 2010 May;87(5):525-7. doi: 10.1038/clpt.2010.29.
10
Partners in discovery.探索伙伴。
Nature. 2018 Mar 22;555(7697):S60. doi: 10.1038/d41586-018-02897-z.
引用本文的文献
1
From Lab to Clinic: Effect of Academia-Industry Collaboration Characteristics on Oncology Phase 1 Trial Entry.从实验室到临床：学术-产业合作特征对肿瘤学1期试验入组的影响。
Clin Transl Sci. 2025 Jan;18(1):e70135. doi: 10.1111/cts.70135.
2
HighVia-A Flexible Live-Cell High-Content Screening Pipeline to Assess Cellular Toxicity.HighVia—一种灵活的活细胞高通量筛选管道，用于评估细胞毒性。
SLAS Discov. 2020 Aug;25(7):801-811. doi: 10.1177/2472555220923979. Epub 2020 May 27.
3
Ideation and implementation of an open science drug discovery business model - M4K Pharma.开放科学药物发现商业模式的构思与实施——M4K制药公司
Wellcome Open Res. 2018 Dec 6;3:154. doi: 10.12688/wellcomeopenres.14947.1. eCollection 2018.
4
The price of progress: Funding and financing Alzheimer's disease drug development.进步的代价：阿尔茨海默病药物研发的资金与融资
Alzheimers Dement (N Y). 2018 Jun 13;4:330-343. doi: 10.1016/j.trci.2018.04.008. eCollection 2018.
5
The Current Status of Drug Discovery and Development as Originated in United States Academia: The Influence of Industrial and Academic Collaboration on Drug Discovery and Development.美国学术界药物发现与开发的现状：工业界与学术界合作对药物发现与开发的影响。
Clin Transl Sci. 2018 Nov;11(6):597-606. doi: 10.1111/cts.12577. Epub 2018 Jul 30.
6
Academic Drug Development: The DRIVE Model.学术药物研发：驱动模型。
ACS Med Chem Lett. 2018 Apr 2;9(5):403-407. doi: 10.1021/acsmedchemlett.8b00124. eCollection 2018 May 10.
7
Data Mining and Computational Modeling of High-Throughput Screening Datasets.高通量筛选数据集的数据挖掘与计算建模
Methods Mol Biol. 2018;1755:197-221. doi: 10.1007/978-1-4939-7724-6_14.
8
Chemotext: A Publicly Available Web Server for Mining Drug-Target-Disease Relationships in PubMed.化文：一个可公开获取的用于从 PubMed 中挖掘药物-靶标-疾病关系的网络服务器。
J Chem Inf Model. 2018 Feb 26;58(2):212-218. doi: 10.1021/acs.jcim.7b00589. Epub 2018 Jan 19.
9
Choose and Use Your Chemical Probe Wisely to Explore Cancer Biology.明智地选择和使用你的化学探针以探索癌症生物学。
Cancer Cell. 2017 Jul 10;32(1):9-25. doi: 10.1016/j.ccell.2017.06.005.
10
Institutional profile: the national Swedish academic drug discovery & development platform at SciLifeLab.机构简介：瑞典国家学术药物研发平台，位于SciLifeLab。
Future Sci OA. 2017 Apr 7;3(2):FSO176. doi: 10.4155/fsoa-2017-0013. eCollection 2017 Jun.
本文引用的文献
1
Academia-industry partnerships in drug discovery.药物研发中的产学研合作。
Expert Opin Drug Discov. 2006 Jun;1(1):1-6. doi: 10.1517/17460441.1.1.1.
2
The emerging academic drug-discovery sector.新兴的学术药物研发领域。
Future Med Chem. 2009 Sep;1(6):1013-7. doi: 10.4155/fmc.09.78.
3
The role of public-sector research in the discovery of drugs and vaccines.公共部门研究在药物和疫苗发现中的作用。
N Engl J Med. 2011 Feb 10;364(6):535-41. doi: 10.1056/NEJMsa1008268.
4
The importance of new companies for drug discovery: origins of a decade of new drugs.新公司在药物发现中的重要性：十年来新药的起源。
Nat Rev Drug Discov. 2010 Nov;9(11):867-82. doi: 10.1038/nrd3251. Epub 2010 Oct 29.
5
Integration of small-molecule discovery in academic biomedical research.小分子发现融入学术生物医学研究。
Mt Sinai J Med. 2010 Jul-Aug;77(4):350-7. doi: 10.1002/msj.20197.
6
How to improve R&D productivity: the pharmaceutical industry's grand challenge.如何提高研发生产力：制药行业的重大挑战。
Nat Rev Drug Discov. 2010 Mar;9(3):203-14. doi: 10.1038/nrd3078. Epub 2010 Feb 19.
7
Lessons from 60 years of pharmaceutical innovation.60年药物创新的经验教训。
Nat Rev Drug Discov. 2009 Dec;8(12):959-68. doi: 10.1038/nrd2961.
8
HTS and hit finding in academia--from chemical genomics to drug discovery.高通量筛选和命中发现于学术界——从化学生物学基因组学到药物发现。
Drug Discov Today. 2009 Dec;14(23-24):1150-8. doi: 10.1016/j.drudis.2009.09.004. Epub 2009 Sep 28.
9
Open access chemical and clinical probes to support drug discovery.支持药物研发的开放获取化学和临床探针。
Nat Chem Biol. 2009 Jul;5(7):436-40. doi: 10.1038/nchembio0709-436.
10
Drug discovery: new models for industry-academic partnerships.药物研发：产学研合作的新模式。
Drug Discov Today. 2009 Jan;14(1-2):95-101. doi: 10.1016/j.drudis.2008.10.003. Epub 2008 Nov 21.
Zotero 插件